BiOkuris is a biotechnology startup based in Belgium that focuses on providing targeted solutions for gut health. The company's slogan, "Targeted solutions for Gut Health," encapsulates its mission to develop the next generation of medical nutrition products tailored to the unmet medical needs of patients with chronic intestinal diseases such as IBD, IBS, and Candidiasis. This innovative approach is aimed at improving both the physiopathology and quality of life for the millions of patients living with chronic intestinal diseases.
BiOkuris was founded in 2022 and operates in the biotechnology industry. The company's commitment to addressing the unmet needs of patients with chronic intestinal diseases positions it as a promising player in the medical nutrition market.
As of now, there is no public information available regarding the last investment raised by BiOkuris or the involved investors. However, the innovative nature of its solutions and the growing demand for targeted treatments for chronic intestinal diseases make BiOkuris an interesting prospect for potential investors looking to support advancements in the biotechnology and medical nutrition sectors.
There is no investment information
No recent news or press coverage available for BiOkuris.